Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - aliskiren hemifumarate 165.75mg equivalent to 150 mg aliskiren;  ;   - film coated tablet - 150 mg - active: aliskiren hemifumarate 165.75mg equivalent to 150 mg aliskiren     excipient: colloidal silicon dioxide crospovidone basic coating premix white basic coating premix red basic coating premix black magnesium stearate microcrystalline cellulose povidone - rasilez is indicated for the treatment of hypertension.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - aliskiren hemifumarate 331.5mg equivalent to 300 mg aliskiren;  ;   - film coated tablet - 300 mg - active: aliskiren hemifumarate 331.5mg equivalent to 300 mg aliskiren     excipient: colloidal silicon dioxide crospovidone basic coating premix white basic coating premix red basic coating premix black magnesium stearate microcrystalline cellulose povidone - rasilez is indicated for the treatment of hypertension.